The clinical trials were continued testing the effectiveness of Tysabri in the treatment of Crohns disease. Patients who have moderate to severe cases of Crohns in which inflammation is present and who find that other Crohns medications dont help them any more will be allowed to take Tysabri. Unfortunately, the clinical trials regarding rheumatoid arthritis have never been resumed.

More: continued here